PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL

被引:9
|
作者
Carofino, Brandi L. [1 ,2 ]
Ayanga, Bernard [2 ]
Tracey, Lauren J. [3 ,4 ]
Brooke-Bisschop, Travis [4 ]
Justice, Monica J. [1 ,2 ,3 ,4 ]
机构
[1] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[3] Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada
[4] Hosp Sick Children, Genet & Genome Biol, Peter Gilgan Ctr Res & Learning, Toronto, ON M5G 0A4, Canada
来源
BIOLOGY OPEN | 2016年 / 5卷 / 05期
基金
美国国家卫生研究院;
关键词
PRDM14; NOTCH1; Driver mutation; RAG recombination; T-cell acute lymphoblastic leukemia; ACUTE LYMPHOBLASTIC-LEUKEMIA; EMBRYONIC STEM-CELLS; SELF-RENEWAL; MICE; CANCER; GENE; DIFFERENTIATION; LEUKEMOGENESIS; ACTIVATION; EXPRESSION;
D O I
10.1242/bio.017699
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
PRDM14 is an epigenetic regulator known for maintaining embryonic stem cell identity and resetting potency in primordial germ cells. However, hematopoietic expression of Prdm14 at supraphysiological levels results in fully penetrant and rapid-onset T-cell acute lymphoblastic leukemia (T-ALL) in the mouse. Here, we show that PRDM14-induced T-ALLs are driven by NOTCH1, a frequently mutated driver of human T-ALL. Notch1 is activated in this murine model via RAG-dependent promoter deletions and subsequent production of truncated, ligand-independent protein from downstream regions of the Notch1 locus. These T-ALLs also have focal changes in H3K4me3 deposition at the Notch1 locus and global increases in both H3K4me1 and H3K4me3. Using a PRDM14-FLAG mouse model, we show that PRDM14 binds within an intron of Notch1 prior to leukemia development. Our data support the idea that PRDM14 binding promotes a chromatin state that allows access of the RAG recombinase complex to cryptic RAG signal sequences embedded at the Notch1 locus. Indeed, breeding into a RAG recombination-deficient background abrogates T-ALL development and prevents Notch1 deletions, while allowing for transient hematopoietic stem cell (HSC)-like pre-leukemia cell expansion. Together, our data suggest that PRDM14 expands a progenitor cell population while promoting a permissive epigenetic state for the creation of driver mutations (here, in Notch1), enabling cancer development through the misappropriation of endogenous cellular DNA recombination machinery.
引用
收藏
页码:645 / 653
页数:9
相关论文
共 24 条
  • [1] Cooperation between somatic Ikaros and Notch1 mutations at the inception of T-ALL
    Sontani, Yovina
    Chapman, Gavin
    Papathanasiou, Peter
    Dunwoodie, Sally
    Goodnow, Christopher C.
    Hoyne, Gerard F.
    LEUKEMIA RESEARCH, 2011, 35 (11) : 1512 - 1519
  • [2] Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL
    Erbilgin, Yucel
    Sayitoglu, Muge
    Hatirnaz, Ozden
    Dogru, Omer
    Akcay, Arzu
    Tuysuz, Gulen
    Celkan, Tiraje
    Aydogan, Gonul
    Salcioglu, Zafer
    Timur, Cetin
    Yuksel-Soycan, Lebriz
    Ure, Umit
    Anak, Sema
    Agaoglu, Leyla
    Devecioglu, Omer
    Yildiz, Inci
    Ozbek, Ugur
    DISEASE MARKERS, 2010, 28 (06) : 353 - 360
  • [3] Targeting the Notch1 and mTOR pathways in a mouse T-ALL model
    Cullion, Kathleen
    Draheim, Kyle M.
    Hermance, Nicole
    Tammam, Jennifer
    Sharma, Vishva M.
    Ware, Christopher
    Nikov, George
    Krishnamoorthy, Veena
    Majumder, Pradip K.
    Kelliher, Michelle A.
    BLOOD, 2009, 113 (24) : 6172 - 6181
  • [4] A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL)
    Carofino, Brandi L.
    Ayanga, Bernard
    Justice, Monica J.
    DISEASE MODELS & MECHANISMS, 2013, 6 (06) : 1494 - 1506
  • [5] An activating intragenic deletion in NOTCH1 in human T-ALL
    Haydu, J. Erika
    De Keersmaecker, Kim
    Duff, Mary Kaye
    Paietta, Elisabeth
    Racevskis, Janis
    Wiernik, Peter H.
    Rowe, Jacob M.
    Ferrando, Adolfo
    BLOOD, 2012, 119 (22) : 5211 - 5214
  • [6] Targeting NOTCH1 in T-ALL: Starving the dragon
    Herranz, Daniel
    Ferrando, Adolfo A.
    CELL CYCLE, 2016, 15 (04) : 483 - 484
  • [7] Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1
    Ashworth, Todd D.
    Pear, Warren S.
    Chiang, Mark Y.
    Blacklow, Stephen C.
    Mastio, Jerome
    Xu, Lanwei
    Kelliher, Michelle
    Kastner, Philippe
    Chan, Susan
    Aster, Jon C.
    BLOOD, 2010, 116 (25) : 5455 - 5464
  • [8] Prognostic Implications of Mutations in NOTCH1 and FBXW7 in Childhood T-ALL Treated According to the NOPHO ALL-1992 and ALL-2000 Protocols
    Fogelstrand, Linda
    Staffas, Anna
    Wasslavik, Carina
    Sjogren, Helene
    Soderhall, Stefan
    Frost, Britt-Marie
    Forestier, Erik
    Degerman, Sofie
    Behrendtz, Mikael
    Heldrup, Jesper
    Karrman, Kristina
    Johansson, Bertil
    Heyman, Mats
    Abrahamsson, Jonas
    Palmqvist, Lars
    PEDIATRIC BLOOD & CANCER, 2014, 61 (03) : 424 - 430
  • [9] Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL
    Tatarek, Jessica
    Cullion, Kathleen
    Ashworth, Todd
    Gerstein, Rachel
    Aster, Jon C.
    Kelliher, Michelle A.
    BLOOD, 2011, 118 (06) : 1579 - 1590
  • [10] Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL
    Hannon, Maura M.
    Lohan, Fiona
    Erbilgin, Yucel
    Sayitoglu, Muge
    O'Hagan, Kathleen
    Mills, Ken
    Ozbek, Ugur
    Keeshan, Karen
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (05) : 626 - 634